Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer

Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer

US Patent 12161733 · Granted Dec 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual-targeting compound and preparation method and application thereof2024
Truncated Evans Blue modified fibroblast activation protein inhibitor, preparati2024
Compound targeting prostate specific membrane antigen, and preparation method an2024
Bicylic compound acting as an inhibitor2022
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and 2021
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and 2021
Chemical conjugates of Evans Blue derivatives and their use in the production of2020
Chemical conjugates of evans blue derivatives and their use as radiotherapy and 2020
Chemical conjugates of evans blue derivatives and their use as radiotherapy and 2020
Imaging agents for imaging protease activity and uses thereof2020
Loudspeaker2019
Labeled evans blue dye derivative for in vivo serum albumin labeling2019